PH25977A - Medicated cleansing pads - Google Patents

Medicated cleansing pads Download PDF

Info

Publication number: PH25977A
Authority: PH; Philippines
Prior art keywords: medicated; pad according; pad; weight; styrene
Prior art date: 1988-02-02

Application number

PH38120A

Other languages

English (en)

Inventor

Lauren Ann Thaman

James Peter Sanogueira

Teresa Marie Petraia

Original Assignee

Richardson Vics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-02

Filing date

1989-01-30

Publication date

1992-01-13

1989-01-30 Application filed by Richardson Vics Inc filed Critical Richardson Vics Inc

1992-01-13 Publication of PH25977A publication Critical patent/PH25977A/en

Links

239000000178 monomer Substances 0.000 claims abstract description 31
KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims abstract description 27
239000000203 mixture Substances 0.000 claims abstract description 26
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 24
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 24
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 12
229960004889 salicylic acid Drugs 0.000 claims abstract description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
239000000463 material Substances 0.000 claims abstract description 10
229920001577 copolymer Polymers 0.000 claims abstract description 9
239000004745 nonwoven fabric Substances 0.000 claims abstract description 8
229920003002 synthetic resin Polymers 0.000 claims abstract description 4
239000007787 solid Substances 0.000 claims abstract description 3
239000002952 polymeric resin Substances 0.000 claims abstract 3
229920005989 resin Polymers 0.000 claims description 24
239000011347 resin Substances 0.000 claims description 24
206010000496 acne Diseases 0.000 claims description 18
208000002874 Acne Vulgaris Diseases 0.000 claims description 15
238000000034 method Methods 0.000 claims description 15
229940119073 medicated pad Drugs 0.000 claims description 12
229940104261 taurate Drugs 0.000 claims description 7
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 7
241001465754 Metazoa Species 0.000 claims description 5
229920000297 Rayon Polymers 0.000 claims description 5
239000002964 rayon Substances 0.000 claims description 5
229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 claims description 3
125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
241000206607 Porphyra umbilicalis Species 0.000 claims 1
150000003440 styrenes Chemical class 0.000 abstract description 3
239000000835 fiber Substances 0.000 description 37
239000000306 component Substances 0.000 description 20
230000003255 anti-acne Effects 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
239000002253 acid Substances 0.000 description 8
239000004744 fabric Substances 0.000 description 7
229920000642 polymer Polymers 0.000 description 6
239000004094 surface-active agent Substances 0.000 description 6
238000000151 deposition Methods 0.000 description 5
229920000742 Cotton Polymers 0.000 description 4
239000002174 Styrene-butadiene Substances 0.000 description 4
230000002745 absorbent Effects 0.000 description 4
239000002250 absorbent Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 4
239000002537 cosmetic Substances 0.000 description 4
230000008021 deposition Effects 0.000 description 4
235000019441 ethanol Nutrition 0.000 description 4
238000005755 formation reaction Methods 0.000 description 4
GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
239000011115 styrene butadiene Substances 0.000 description 4
229920003048 styrene butadiene rubber Polymers 0.000 description 4
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000002361 compost Substances 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000002245 particle Substances 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
210000002374 sebum Anatomy 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
239000002904 solvent Substances 0.000 description 3
238000005303 weighing Methods 0.000 description 3
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
229920002972 Acrylic fiber Polymers 0.000 description 2
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
241000723346 Cinnamomum camphora Species 0.000 description 2
241000208680 Hamamelis mollis Species 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
206010033733 Papule Diseases 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
230000003113 alkalizing effect Effects 0.000 description 2
125000000129 anionic group Chemical group 0.000 description 2
239000003945 anionic surfactant Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229960000846 camphor Drugs 0.000 description 2
229930008380 camphor Natural products 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
230000008859 change Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
239000003205 fragrance Substances 0.000 description 2
235000021588 free fatty acids Nutrition 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
230000008569 process Effects 0.000 description 2
-1 salicylic actd Chemical compound 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
239000002002 slurry Substances 0.000 description 2
210000000434 stratum corneum Anatomy 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000004753 textile Substances 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
229940118846 witch hazel Drugs 0.000 description 2
210000002268 wool Anatomy 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 description 1
PETPJXCKASLNTF-UHFFFAOYSA-N 2-methylbuta-1,3-diene;3-methylidenepent-1-ene Chemical compound CC(=C)C=C.CCC(=C)C=C PETPJXCKASLNTF-UHFFFAOYSA-N 0.000 description 1
JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
229920013659 Acele Polymers 0.000 description 1
208000020154 Acnes Diseases 0.000 description 1
244000198134 Agave sisalana Species 0.000 description 1
244000144927 Aloe barbadensis Species 0.000 description 1
235000002961 Aloe barbadensis Nutrition 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
240000008564 Boehmeria nivea Species 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
240000000491 Corchorus aestuans Species 0.000 description 1
235000011777 Corchorus aestuans Nutrition 0.000 description 1
235000010862 Corchorus capsularis Nutrition 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
241000186427 Cutibacterium acnes Species 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
229920004934 Dacron® Polymers 0.000 description 1
206010061619 Deformity Diseases 0.000 description 1
102100030796 E3 ubiquitin-protein ligase rififylin Human genes 0.000 description 1
101710128004 E3 ubiquitin-protein ligase rififylin Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
241000219146 Gossypium Species 0.000 description 1
101000831887 Homo sapiens STE20-related kinase adapter protein alpha Proteins 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
229920002821 Modacrylic Polymers 0.000 description 1
229920002292 Nylon 6 Polymers 0.000 description 1
229920002302 Nylon 6,6 Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
229920001131 Pulp (paper) Polymers 0.000 description 1
206010037888 Rash pustular Diseases 0.000 description 1
102100024171 STE20-related kinase adapter protein alpha Human genes 0.000 description 1
235000014328 Schoenoplectus acutus var occidentalis Nutrition 0.000 description 1
244000136421 Scirpus acutus Species 0.000 description 1
235000014326 Scirpus californicus Nutrition 0.000 description 1
235000017913 Scirpus lacustris Nutrition 0.000 description 1
206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
239000005864 Sulphur Substances 0.000 description 1
208000033809 Suppuration Diseases 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
206010047642 Vitiligo Diseases 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
WTHXTWHYLIZJBH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTHXTWHYLIZJBH-UHFFFAOYSA-N 0.000 description 1
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
235000011399 aloe vera Nutrition 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229940037003 alum Drugs 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
239000003212 astringent agent Substances 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000019400 benzoyl peroxide Nutrition 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
QNRMTGGDHLBXQZ-UHFFFAOYSA-N buta-1,2-diene Chemical compound CC=C=C QNRMTGGDHLBXQZ-UHFFFAOYSA-N 0.000 description 1
235000009120 camo Nutrition 0.000 description 1
238000009960 carding Methods 0.000 description 1
239000000969 carrier Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
235000005607 chanvre indien Nutrition 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000002995 comedolytic effect Effects 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000009833 condensation Methods 0.000 description 1
210000000736 corneocyte Anatomy 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
230000037416 cystogenesis Effects 0.000 description 1
230000010339 dilation Effects 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000003325 follicular Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
230000009477 glass transition Effects 0.000 description 1
239000011487 hemp Substances 0.000 description 1
KETWBQOXTBGBBN-UHFFFAOYSA-N hex-1-enylbenzene Chemical compound CCCCC=CC1=CC=CC=C1 KETWBQOXTBGBBN-UHFFFAOYSA-N 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000003780 keratinization Effects 0.000 description 1
230000003902 lesion Effects 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
239000006210 lotion Substances 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
244000005700 microbiome Species 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
239000000820 nonprescription drug Substances 0.000 description 1
239000002674 ointment Substances 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000003405 preventing effect Effects 0.000 description 1
208000029561 pustule Diseases 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000004627 regenerated cellulose Substances 0.000 description 1
SHGAZHPCJJPHSC-YCNIQYBTSA-N retinoic acid group Chemical class C\C(=C/C(=O)O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
230000037390 scarring Effects 0.000 description 1
208000008742 seborrheic dermatitis Diseases 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
IZWPGJFSBABFGL-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS([O-])(=O)=O IZWPGJFSBABFGL-GMFCBQQYSA-M 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000000057 synthetic resin Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/48—Surfactants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Birds (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Detergent Compositions (AREA)
Materials For Medical Uses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Production Of Multi-Layered Print Wiring Board (AREA)
External Artificial Organs (AREA)
Media Introduction/Drainage Providing Device (AREA)

PH38120A 1988-02-02 1989-01-30 Medicated cleansing pads PH25977A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/151,338 US4891228A (en)	1988-02-02	1988-02-02	Medicated cleansing pads

Publications (1)

Publication Number	Publication Date
PH25977A true PH25977A (en)	1992-01-13

Family

ID=22538308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH38120A PH25977A (en)	1988-02-02	1989-01-30	Medicated cleansing pads

Country Status (17)

Country	Link
US (1)	US4891228A (de)
EP (1)	EP0327326B1 (de)
JP (1)	JP2885815B2 (de)
KR (1)	KR0136273B1 (de)
AT (1)	ATE89998T1 (de)
AU (1)	AU613295B2 (de)
CA (1)	CA1337897C (de)
DE (1)	DE68906804T2 (de)
DK (1)	DK47789A (de)
ES (1)	ES2040994T3 (de)
GR (1)	GR3008079T3 (de)
HK (1)	HK1006146A1 (de)
IE (1)	IE62870B1 (de)
MX (1)	MX165382B (de)
MY (1)	MY105806A (de)
NZ (1)	NZ227823A (de)
PH (1)	PH25977A (de)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4891227A (en) *	1988-02-02	1990-01-02	Richardson-Vicks Inc.	Medicated cleansing pads
US5780459A (en) *	1991-11-25	1998-07-14	The Procter & Gamble Company	Compositions for regulating skin wrinkles and or skin atrophy
WO1993010756A1 (en) *	1991-11-25	1993-06-10	Richardson-Vicks, Inc.	Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
WO1993010755A1 (en) *	1991-11-25	1993-06-10	Richardson-Vicks, Inc.	Compositions for regulating skin wrinkles and/or skin atrophy
US5466456A (en) *	1991-11-27	1995-11-14	Glover; Morris S.	Facial cleanser
WO1993021899A1 (en) *	1992-05-05	1993-11-11	The Procter & Gamble Company	Acne treating composition
FI950345A7 (fi) *	1992-07-27	1995-01-26	Procter & Gamble	Laminoituja kaksoisteksturoituja hoitotyynyjä
CA2159985C (en) *	1993-04-20	1999-07-13	Raphael Warren	Methods of using hesperetin for sebum control and treatment of acne
WO1994027569A1 (en) *	1993-06-01	1994-12-08	Dermatology Home Products, Inc.	Skin treatment method utilizing a composition and a pad
US5505948A (en) *	1993-06-01	1996-04-09	Dermatology Home Products, Inc.	Home skin peel composition for producing healthy and attractive skin
US6103644A (en)	1993-12-22	2000-08-15	Nordico Marketing Development, Inc.	Impregnated matrix and method for making same
US5549888A (en) *	1994-01-31	1996-08-27	Procter & Gamble	Aqueous topical anti-acne compositions of low pH
US5538732A (en) *	1994-04-12	1996-07-23	Creative Products Resource, Inc.	Medicated applicator sheet for topical drug delivery
US5558873A (en) *	1994-06-21	1996-09-24	Kimberly-Clark Corporation	Soft tissue containing glycerin and quaternary ammonium compounds
US5976521A (en) *	1994-08-09	1999-11-02	The Procter & Gamble Company	Anti-acne cosmetic compositions
US5665426A (en) *	1995-02-06	1997-09-09	Kimberly-Clark Corporation	Soft treated tissue
US5601871A (en) *	1995-02-06	1997-02-11	Krzysik; Duane G.	Soft treated uncreped throughdried tissue
AU721214B2 (en)	1996-02-08	2000-06-29	Albert M. Kligman	Composition and method for effecting superficial chemical skin peels
US5741497A (en) *	1996-06-25	1998-04-21	Elizabeth Arden Company	Skin treatment with salicylic acid esters
US5891451A (en) *	1996-06-25	1999-04-06	Elizabeth Arden Company, Division Of Conopco, Inc.	Skin treatment with salicylic acid esters
US5972361A (en) *	1996-10-25	1999-10-26	The Procter & Gamble Company	Cleansing products
US6338855B1 (en)	1996-10-25	2002-01-15	The Procter & Gamble Company	Cleansing articles for skin and/or hair which also deposit skin care actives
US6063397A (en) *	1996-10-25	2000-05-16	The Procter & Gamble Company	Disposable cleansing products for hair and skin
US5773015A (en) *	1996-11-27	1998-06-30	Elizabeth Arden Co., Division Of Conopco, Inc.	Method for controlling skin oils and grease
US5728732A (en) *	1996-11-27	1998-03-17	Elizabeth Arden Company, Division Of Conopco, Inc.	Skin treatment with salicylic acid esters and retinoids
US5885697A (en) *	1996-12-17	1999-03-23	Kimberly-Clark Worldwide, Inc.	Soft treated tissue
AU724588B2 (en) *	1997-04-09	2000-09-28	Kao Corporation	Skin cleansing sheet
US5951991A (en) *	1997-05-22	1999-09-14	The Procter & Gamble Company	Cleansing products with improved moisturization
US6280757B1 (en)	1997-05-22	2001-08-28	The Procter & Gamble Company	Cleansing articles for skin or hair
US6132746A (en) *	1997-05-22	2000-10-17	The Procter & Gamble Company	Cleansing products with improved moisturization
US6190674B1 (en)	1997-06-04	2001-02-20	Procter & Gamble Company	Liquid antimicrobial cleansing compositions
US6214363B1 (en)	1997-11-12	2001-04-10	The Procter & Gamble Company	Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6210695B1 (en)	1997-06-04	2001-04-03	The Procter & Gamble Company	Leave-on antimicrobial compositions
US6287577B1 (en)	1997-11-12	2001-09-11	The Procter & Gamble Company	Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6183757B1 (en)	1997-06-04	2001-02-06	Procter & Gamble Company	Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6183763B1 (en)	1997-06-04	2001-02-06	Procter & Gamble Company	Antimicrobial wipes which provide improved immediate germ reduction
US6258368B1 (en) *	1997-06-04	2001-07-10	The Procter & Gamble Company	Antimicrobial wipes
US6284259B1 (en)	1997-11-12	2001-09-04	The Procter & Gamble Company	Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US5968539A (en) *	1997-06-04	1999-10-19	Procter & Gamble Company	Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6197315B1 (en)	1997-06-04	2001-03-06	Procter & Gamble Company	Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6190675B1 (en)	1997-06-04	2001-02-20	Procter & Gamble Company	Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
WO1999012519A1 (en)	1997-09-05	1999-03-18	The Procter & Gamble Company	Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients
DE69808790T3 (de) *	1997-09-12	2009-07-16	The Procter & Gamble Co., Cincinnati	Hautreinigungs- und konditionierungsartikel für haut und haar
US6287583B1 (en)	1997-11-12	2001-09-11	The Procter & Gamble Company	Low-pH, acid-containing personal care compositions which exhibit reduced sting
FR2774287B1 (fr) *	1998-01-30	2000-05-12	Oreal	Patch nettoyant, revelateur de l'etat de la peau
US6962904B1 (en) *	1998-03-13	2005-11-08	Connective Tissue Imagineering	Elastin peptide analogs and uses thereof
US6809075B1 (en)	2000-05-30	2004-10-26	Connective Tissue Imagineering Llc	Elastin peptide analogs and uses of same incombination with skin enhancing agents
EP1068853A4 (de) *	1998-03-30	2005-09-21	Kao Corp	Bedeckender film für haut und haare
JP2002512944A (ja) *	1998-04-24	2002-05-08	ザ、プロクター、エンド、ギャンブル、カンパニー	スキンケア活性剤が沈着する皮膚及び／又は毛髪のための洗浄剤物品
US6106818A (en) *	1998-04-27	2000-08-22	Revlon Consumer Products Corporation	Method for removing dead surface cells, dirt, oil, and blackheads from the skin and related compositions and articles
US6777389B1 (en)	1998-11-19	2004-08-17	Connective Tissue Imagineering Llc	Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
US6537933B1 (en) *	1999-02-17	2003-03-25	Yuzo Tsuchida	Silk cloths for protecting affected parts
US6413529B1 (en) *	1999-04-13	2002-07-02	The Procter & Gamble Company	Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6482423B1 (en)	1999-04-13	2002-11-19	The Procter & Gamble Company	Antimicrobial wipes which provide improved residual benefit versus gram positive bacteria
US6488943B1 (en)	1999-04-13	2002-12-03	The Procter & Gamble Company	Antimicrobial wipes which provide improved immediate germ reduction
US6319510B1 (en)	1999-04-20	2001-11-20	Alayne Yates	Gum pad for delivery of medication to mucosal tissues
US6242491B1 (en)	1999-06-25	2001-06-05	Rima Kaddurah-Daouk	Use of creatine or creatine compounds for skin preservation
US6296869B1 (en)	1999-07-30	2001-10-02	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Adhesive cosmetic patch containing alpha or beta hydroxy acids
US6428798B1 (en) *	1999-08-24	2002-08-06	Lisa Bachrach	Blemish extraction means
US6355261B1 (en)	1999-12-02	2002-03-12	The C. P. Hall Company	Ultraviolet radiation absorbing waxes useful in cosmetic compositions
MXPA02006540A (es)	1999-12-30	2002-12-09	Kimberly Clark Co	Articulo absorbente anitmicrobial y metodos para hacer y usar el mismo.
WO2001080827A2 (en) *	2000-04-21	2001-11-01	Nature's Cure	Salicylic acid acne spray formulations and methods for treating acne with same
US6794362B1 (en)	2000-05-30	2004-09-21	Connective Tissue Imagineering Llc	Asparagine containing elastin peptide analogs
CA2422199A1 (en) *	2000-09-08	2002-03-14	Johnson & Johnson Consumer Companies Inc.	Stable emulsions useful for skin care wipes
US20020192407A1 (en) *	2001-03-01	2002-12-19	The Procter & Gamble Company	Pre-moistened wipe with improved feel and softness
US20030059459A1 (en)	2001-09-14	2003-03-27	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Method of treating hair with heat and a cap which provides a signal regarding treatment
US6692637B2 (en) *	2001-11-07	2004-02-17	Tetra Holding (Us), Inc.	Dual density filter cartridge
DE10205193A1 (de) *	2002-02-08	2003-08-21	Beiersdorf Ag	Diolhaltige Reinigungszubereitungen
US7115551B2 (en) *	2002-06-07	2006-10-03	The Procter & Gamble Company	Cleansing articles for skin or hair
US20030228352A1 (en) *	2002-06-07	2003-12-11	The Procter & Gamble Company	Cleansing articles for skin or hair
US20050025817A1 (en) *	2003-07-03	2005-02-03	Bhatia Kuljit S.	Delivery system for topical medications
US7776355B2 (en) *	2003-07-03	2010-08-17	Medics Pharmaceutical Corporation	Delivery system for topical medications
US20050202068A1 (en)	2004-03-12	2005-09-15	Hasenoehrl Erik J.	Disposable nonwoven mitt
US7479289B2 (en) *	2004-07-02	2009-01-20	Medicis Pharmaceutical Corporation	Stable cleanser compositions containing sulfur
US7655682B2 (en) *	2004-07-02	2010-02-02	Medicis Pharmaceutical Corporation	Triple anti-irritant composition
CA2585398A1 (en) *	2004-11-12	2006-05-18	The Procter & Gamble Company	Treatment articles capable of conforming to an underlying shape
AU2006265816B2 (en) *	2005-07-01	2012-05-03	Playtex Products, Inc.	Sunless tanning substrate
BRPI0710672A2 (pt) *	2006-04-07	2011-08-16	Reckitt Benckiser	artigo para cuidados pessoais
US20080025917A1 (en) *	2006-04-10	2008-01-31	Malcolm Whitman	Methods for modulating formation and progression of cellulite
US20080041319A1 (en)	2006-04-25	2008-02-21	The Iams Company	Disposable wet nonwoven implement
US8475817B2 (en) *	2006-07-31	2013-07-02	The Procter & Gamble Company	Cleansing articles for skin or hair
USD592860S1 (en)	2006-07-31	2009-05-26	The Procter & Gamble Company	Cleansing cloth with pattern design
US20090105196A1 (en) *	2007-06-22	2009-04-23	Belinda Tsao Nivaggioli	Use of creatine compounds to treat dermatitis
WO2009023267A2 (en) *	2007-08-15	2009-02-19	President And Fellows Of Harvard College	Methods for modulating development and expansion of il-17 expressing cells
US20090123389A1 (en) *	2007-08-15	2009-05-14	Malcolm Whitman	Methods for modulating Th17 cell development in the treatment and prevention of cellulite
AU2009282480B2 (en)	2008-08-11	2015-05-07	Children's Medical Center Corporation	Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
US8262907B1 (en)	2010-01-27	2012-09-11	Central Garden And Pet Company	Composite sock filter for aquariums
CN101953654A (zh) *	2010-04-19	2011-01-26	铜陵洁雅生物科技股份有限公司	消毒清洁湿巾及其制备方法
WO2012153336A2 (en)	2011-05-12	2012-11-15	Rakuto Bio Technologies Ltd.	Methods and device for lightening skin complexion
US10155742B2 (en)	2012-01-13	2018-12-18	President And Fellows Of Harvard College	Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
US8558008B2 (en)	2013-02-28	2013-10-15	Dermira, Inc.	Crystalline glycopyrrolate tosylate
US9006462B2 (en)	2013-02-28	2015-04-14	Dermira, Inc.	Glycopyrrolate salts
JP6114841B2 (ja)	2013-02-28	2017-04-12	ダーミラ，インク．Ｄｅｒｍｉｒａ，Ｉｎｃ．	グリコピロレート塩
EP3666950B1 (de)	2014-08-07	2021-06-09	GPCP IP Holdings LLC	Strukturierter, dispergierbarer vliesstoff aus vernadelten fasern
CN107205989A (zh)	2014-11-14	2017-09-26	梅琳塔治疗公司	治疗、预防或降低皮肤感染风险的方法
US20170333400A1 (en)	2016-05-17	2017-11-23	Melinta Therapeutics, Inc.	Topical formulations of biaryl heterocyclic compounds and methods of use thereof
EP3703668A1 (de) *	2017-11-01	2020-09-09	Clexio Biosciences Ltd.	Fertige faserstrukturen und verfahren zu deren verwendung und herstellung
EP3801525A4 (de)	2018-06-08	2022-03-23	The General Hospital Corporation	Inhibitoren der prolyl-trna-synthetase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US28957A (en) *		1860-07-03		Steam-engine
US3550593A (en) *	1967-02-02	1970-12-29	Jack W Kaufman	Therapeutic apparatus
US3706595A (en) *	1971-01-22	1972-12-19	Johnson & Johnson	Method of applying a resin binder to a substrate
US3778341A (en) *	1971-03-17	1973-12-11	Johnson & Johnson	Nonwoven textile fabrics and methods of making the same
USRE28957E (en)	1972-06-07	1976-09-07	Johnson & Johnson	Synthetic resin compositions and methods of utilizing the same
JPS50150649A (de) *	1974-05-25	1975-12-03
JPS5579316A (en) *	1978-12-13	1980-06-14	Nippon Ratetsukusu Kako Kk	Toilet napkin
US4341213A (en) *	1981-08-13	1982-07-27	The Kendall Co.	Bonded nonwoven fabrics
US4514385A (en) *	1981-10-05	1985-04-30	Alcon Laboratories, Inc.	Anti-acne compositions
EP0093186B1 (de) *	1982-05-03	1986-07-09	Richardson Vicks Limited	Pharmazeutisches Präparat zur topischen Behandlung von Akne
GB2156215B (en) *	1984-03-05	1988-03-02	Nitto Electric Ind Co	Percutaneous absorption type adhesive pharmaceutical preparation
JPS61280426A (ja) *	1985-06-04	1986-12-11	Ikeda Mohandou:Kk	消炎鎮痛用貼付剤
US4769022A (en) *	1986-05-02	1988-09-06	Minnesota Mining And Manufacturing Company	Cleansing pad
US4830854A (en) *	1987-12-18	1989-05-16	James B. Copelan	Chemical splinter removal
WO1989010738A1 (en) *	1988-05-09	1989-11-16	Solarcare, Inc.	Sunscreen composition and applicator system

1988
- 1988-02-02 US US07/151,338 patent/US4891228A/en not_active Expired - Lifetime
1989
- 1989-01-27 MY MYPI89000103A patent/MY105806A/en unknown
- 1989-01-30 PH PH38120A patent/PH25977A/en unknown
- 1989-02-01 KR KR1019890001141A patent/KR0136273B1/ko not_active Expired - Fee Related
- 1989-02-01 ES ES198989300950T patent/ES2040994T3/es not_active Expired - Lifetime
- 1989-02-01 AU AU29523/89A patent/AU613295B2/en not_active Ceased
- 1989-02-01 AT AT89300950T patent/ATE89998T1/de active
- 1989-02-01 EP EP89300950A patent/EP0327326B1/de not_active Expired - Lifetime
- 1989-02-01 NZ NZ227823A patent/NZ227823A/en unknown
- 1989-02-01 DE DE89300950T patent/DE68906804T2/de not_active Expired - Fee Related
- 1989-02-01 CA CA000589784A patent/CA1337897C/en not_active Expired - Fee Related
- 1989-02-01 IE IE32189A patent/IE62870B1/en not_active IP Right Cessation
- 1989-02-02 JP JP1024738A patent/JP2885815B2/ja not_active Expired - Lifetime
- 1989-02-02 DK DK047789A patent/DK47789A/da not_active Application Discontinuation
- 1989-02-02 MX MX014754A patent/MX165382B/es unknown
1993
- 1993-06-03 GR GR920403263T patent/GR3008079T3/el unknown
1998
- 1998-06-01 HK HK98104734A patent/HK1006146A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
MX165382B (es)	1992-11-06
NZ227823A (en)	1991-06-25
KR0136273B1 (ko)	1998-04-25
US4891228A (en)	1990-01-02
CA1337897C (en)	1996-01-09
ES2040994T3 (es)	1993-11-01
ATE89998T1 (de)	1993-06-15
DE68906804D1 (de)	1993-07-08
JPH021408A (ja)	1990-01-05
KR890012656A (ko)	1989-09-18
EP0327326A1 (de)	1989-08-09
IE890321L (en)	1989-08-02
HK1006146A1 (en)	1999-02-12
EP0327326B1 (de)	1993-06-02
DK47789D0 (da)	1989-02-02
DK47789A (da)	1989-08-03
AU2952389A (en)	1989-08-03
GR3008079T3 (de)	1993-09-30
JP2885815B2 (ja)	1999-04-26
AU613295B2 (en)	1991-07-25
MY105806A (en)	1995-01-30
IE62870B1 (en)	1995-03-08
DE68906804T2 (de)	1993-11-18

Publication	Publication Date	Title
PH25977A (en)	1992-01-13	Medicated cleansing pads
EP0327327B1 (de)	1994-06-01	Medizinische Reinigungstupfer
HK1006146B (en)	1999-02-12	Medicated cleansing pads
HK1007507B (en)	1999-04-16	Medicated cleansing pads
EP0652988B1 (de)	1998-04-01	Laminierte doppelt texturierte behandlungspads
EP0735866B1 (de)	2001-02-21	Antimikrobielle zusammensetzungen für abwischtücher
CN1221208C (zh)	2005-10-05	清洗擦拭件及其制造方法
GB2222526A (en)	1990-03-14	Cleansing pack
CA2445489A1 (en)	2002-10-10	Metronidazole pledgets
US20070099812A1 (en)	2007-05-03	Exothermic cleansing article
JPH09268122A (ja)	1997-10-14	貼付剤組成物
MXPA97003394A (en)	1997-12-01	Wipes for cleaning treated with emulsion of water in lipi